" /> Chk1 Inhibitor SRA737 - CISMeF





Preferred Label : Chk1 Inhibitor SRA737;

NCIt synonyms : Checkpoint Kinase 1 Inhibitor CCT245737; (R)-5-((4-((Morpholin-2-ylmethyl)amino)-5-(trifluoromethyl)pyridin-2-yl)amino)pyrazine-2-carbonitrile; Chk1 Inhibitor CCT245737;

NCIt related terms : SRA-737;

NCIt definition : An orally bioavailable inhibitor of checkpoint kinase 1 (chk1), with potential antineoplastic and chemosensitization activities. Upon oral administration, chk1 inhibitor SRA737 selectively binds to chk1, thereby preventing chk1 activity and abrogating the repair of damaged DNA. This may lead to an accumulation of damaged DNA, inhibition of cell cycle arrest, and induction of apoptosis. SRA737 may potentiate the cytotoxicity of DNA-damaging agents and reverse tumor cell resistance to chemotherapeutic agents. Chk1, an adenosine triphosphate (ATP)-dependent serine/threonine kinase overexpressed in a variety of cancer cell types, mediates cell cycle checkpoint control and is essential for DNA repair; it plays a key role in resistance to chemotherapeutic agents by repairing DNA damage.;

UNII : QB6LNL4NF6;

CAS number : 1489389-18-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 1489389-18-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : CCT245737; SRA 737; PNT-737; SRA-737;

NCI Metathesaurus CUI : CL512598;

Details


You can consult :


Nous contacter.
15/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.